Skip to main content
Caplight Logo









GT Medical Technologies

GT Medical Technologies

Private
Tempe, ArizonaHealthcare & Life Scienceshttps://gammatile.com

Last Round

Series E

Jun 9, 2026

Total Funding Raised

$262M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

GT Medical Technologies operates in Healthcare & Life Sciences and is based in Tempe, Arizona. Its latest recorded funding round was a Series E round in June 2026.

GT Medical Technologies is a medical device company that develops innovative therapeutic solutions, including the FDA-cleared GammaTile Therapy, to improve outcomes for patients with operable brain tumors.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

GT Medical Technologies Comparables

Compare GT Medical Technologies with similar companies based on industry and business-model similarity.

GT Medical Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alpha Tau Medical
76%
Azurity Pharmaceuticals
75%
ZAP Surgical Systems
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

GT Medical Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EJun 9, 2026
Series DJul 15, 2025
DebtSep 12, 2024
Series CMar 23, 2023
Series BNov 23, 2020
Series A
Feb 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Per Langoe

Chief Executive Officer

Executive Team

David Brachman

Chief Technology Officer

Executive Team

Ole Mikkelsen

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

GT Medical Technologies Investors

Notable investors and investment history

GT Medical Technologies investors
InvestorRounds
Evidity Health CapitalSeries E, Series D
Gilde HealthcareSeries E, Series D, Series C
Medical Technology Venture PartnersSeries E, Series D, Series C, Series B, Series A, Seed
Warren Point CapitalSeries D
Viking Global InvestorsSeries E
Horizon Technology Finance CorporationDebt
BlueStone Venture PartnersSeries A, Series C, Series B
Book a demo to see all 10 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 9, 2026

    $100M round led by Viking Global Investors

  • Jul 15, 2025

    $53M round completed.

Book a demo to see all signals

For institutional investors. Book with your work email.

GT Medical Technologies Filings

Explore SEC and related filing metadata, where available.

GT Medical Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about GT Medical Technologies's valuation, stock price, and market status.

Is GT Medical Technologies a public or private company?

GT Medical Technologies is a private company.

What is the current stock price of GT Medical Technologies?

GT Medical Technologies is a private company, so its shares have no public market price. Caplight tracks GT Medical Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is GT Medical Technologies worth (valuation)?

Valuation information for GT Medical Technologies is not publicly available.

Can I buy GT Medical Technologies stock?

GT Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was GT Medical Technologies's last funding round?

GT Medical Technologies's most recent funding round was Series E on June 9, 2026.

Who are the main investors in GT Medical Technologies?

Key investors in GT Medical Technologies include Evidity Health Capital, Gilde Healthcare, Medical Technology Venture Partners, Viking Global Investors, MVM Life Science Partners LLP.

Will GT Medical Technologies IPO soon?

No public IPO plans have been announced for GT Medical Technologies.

How can I track GT Medical Technologies secondary market activity?

Caplight tracks bids, offers, and trades in GT Medical Technologies's shares on secondary markets.

Firmographic Details

HeadquartersTempe, Arizona
Employee Range87
Year Founded2017
Last FundingJun 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?